← Back to catalogue
SENSINITRYL versione TOP DOWN
EUDAMEDClass I (EU MDR)
Ref 39970 PModel GUANTO IN NITRILERef 39971 PRef 39972 PRef 39973 P
Identity
- Trade Name
- SENSINITRYL versione TOP DOWN EUDAMED
- Device Name
- GUANTO MONOUSO IN NITRILE SENZA POLVERE EUDAMED
- Model / Reference
- GUANTO IN NITRILE EUDAMED39970 P EUDAMED39971 P EUDAMED39972 P EUDAMED39973 P EUDAMED
Identifiers
- Primary DI / UDI-DI
- 08024151813670 EUDAMED08024151813687 EUDAMED08024151813694 EUDAMED08024151815926 EUDAMED
- Basic UDI-DI
- 8024151GUNSYY EUDAMED
- Direct Marketing DI
- 08024151813670 EUDAMED08024151813687 EUDAMED08024151813694 EUDAMED08024151815926 EUDAMED
- EMDN Code
- T01020204 NITRILE EXAMINATION / TREATMENT GLOVES EUDAMED
Classification
- Device Class
- Class I EUDAMED
- Market of Registration
- Italy EUDAMED
Clinical & Handling
Sterile
No
EUDAMED
Implantable
No
EUDAMED
Reusable
No
EUDAMED
Contains Latex
No
EUDAMED
Reprocessed
No
EUDAMED
CMR Substance
No
EUDAMED
Human-derived
No
EUDAMED
Human Tissues
No
EUDAMED
Animal Tissues
No
EUDAMED
Endocrine Disruptor
No
EUDAMED
Administering Medicine
No
EUDAMED
Measuring Function
No
EUDAMED
Incorporates Medicinal Product
No
EUDAMED
SENSINITRYL versione TOP DOWN by Bericah S.p.A. — Class I — MDR — listed in EUDAMED — regulatory data on deviCERTS
Authorization Coverage (European Union — 27 member states)
Regulatory Authorizations
European Union Active
CE/MDR
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| EUDAMED | European Union | CE/MDR | 8024151GUNSYY | Class I | Active |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Bericah S.p.A.
- EUDAMED SRN
- IT-MF-000007397
Sources (4)
- EUDAMED f17f72b6-e60a-428c-b6df-4de05d4f1374 61 fields · synced Jul 20, 2026
- EUDAMED b302d692-fe8f-46ad-8da7-99df4afcf359 61 fields · synced May 18, 2026
- EUDAMED 7e3afbab-7a08-49a2-bfb4-01bc03eff968 61 fields · synced May 18, 2026
- EUDAMED b575b6f8-d854-4852-8596-f99fb1d99525 61 fields · synced May 19, 2026